1. Home
  2. EHI vs ANTX Comparison

EHI vs ANTX Comparison

Compare EHI & ANTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Western Asset Global High Income Fund Inc

EHI

Western Asset Global High Income Fund Inc

BUY

Current Price

$5.39

Market Cap

163.9M

Sector

Finance

ML Signal

BUY

Logo AN2 Therapeutics Inc.

ANTX

AN2 Therapeutics Inc.

HOLD

Current Price

$5.28

Market Cap

172.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EHI
ANTX
Founded
N/A
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
163.9M
172.9M
IPO Year
2003
2022

Fundamental Metrics

Financial Performance
Metric
EHI
ANTX
Price
$5.39
$5.28
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
★ $9.00
AVG Volume (30 Days)
137.2K
★ 223.7K
Earning Date
01-01-0001
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 32.56
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.35
$1.00
52 Week High
$6.56
$7.19

Technical Indicators

Market Signals
Indicator
EHI
ANTX
Relative Strength Index (RSI) 30.87 48.38
Support Level $5.35 $4.61
Resistance Level $6.03 $7.05
Average True Range (ATR) 0.06 0.38
MACD -0.00 0.05
Stochastic Oscillator 22.00 49.58

Price Performance

Historical Comparison
EHI
ANTX

About EHI Western Asset Global High Income Fund Inc

Western Asset Global High Inc Fd Inc is a non-diversified, closed-end management investment company. Its investment objective is high current income. The Fund's secondary investment objective is total return. It invests in an international portfolio of securities consisting of below-investment-grade fixed income securities, emerging market fixed income securities, and investment-grade fixed income securities. The Fund's investment portfolio comprises sovereign bonds, collateralized mortgage obligations, asset-backed securities, and fixed income securities from different corporate sectors, including financials, energy, consumer discretionary, and industrials, among others.

About ANTX AN2 Therapeutics Inc.

AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology. Product candidate AN2-502998 Epetraborole.

Share on Social Networks: